Validation of the NCCLS proposal to use results only from the first isolate of a species per patient in the calculation of susceptibility frequencies | Zendy

Kevin Shan | Zendy

Open Access

Validation of the NCCLS proposal to use results only from the first isolate of a species per patient in the calculation of susceptibility frequencies

Author(s) -

Kevin Shan

Publication year - 2002

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkf225

Subject(s) - cefuroxime , gentamicin , antimicrobial , antibiotics , staphylococcus aureus , vancomycin , microbiology and biotechnology , amoxicillin , klebsiella , medicine , biology , escherichia coli , bacteria , genetics , gene

A recently proposed guideline from the NCCLS recommends that results only from the first isolate of a species per patient be used in calculation of percentage susceptibilities to antimicrobial agents. Because this is apparently based on the comparison of various calculation methods for results for oxacillin against a fairly small number of isolates of Staphylococcus aureus, we have applied these methods to a wider range of antibiotic/organism combinations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research